Clinical Trials in Parma, Emilia-Romagna
4 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Hoffmann-La Roche1,050 enrolled351 locationsNCT06065748
Recruiting
Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Cancer
Bayer402 enrolled383 locationsNCT04464226
Recruiting
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
MyelofibrosisPrimary MyelofibrosisSecondary Myelofibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna1,055 enrolled26 locationsNCT06516406
Recruiting
Use of miRNAs in Growth Hormone Deficiency (GHD)
Growth Hormone Deficiency
University of Parma400 enrolled1 locationNCT06455956